Morales, Florefil A.
HRN: 08-93-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2024
CEFUROXIME 1.5GM (VIAL)
12/29/2024
12/30/2024
IV
1.5
Q8
1LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes